In addition, a Boolean model derived from a smaller network-module representing the crosstalk between FLT3, DNMT3A, NPM1 and cancer hallmarks, when primed with patient-specific genomic profiles, yielded predictions that are in accord with patients’ clinical data. The gene discussed is DNMT3A; the disease is cancer.